scholarly journals Effect of GnRH and D-Chloprostenol application on pregnancy and prolificacy rates on Pelibuey ewes

2013 ◽  
pp. 3612-3617 ◽  
Author(s):  
Jaime Martínez T ◽  
Oziel Montañez V ◽  
Alejandro Ley De C ◽  
Fernando Izaguirre F ◽  
María Velazco Z ◽  
...  

ABSTRACTObjective. Was to evaluate the effect of GnRH and D-Chloprostenol application on pregnancy and prolificacy rates on Pelibuey ewes. Materials and methods. Forty five ewes were randomly allocated to one of three treatments: T1(n=15), day 0: sponges with 65 mg medroxyprogesterone acetate (MPA) + 200 IU equine chorionic gonadotropin (eCG) and sponge removal (day 12) + breeding by natural mating (days 12-15); T2 (n=15), day 0: 50 μg gonadotropin releasing hormone (GnRH) + 7.5 mg D-Chloprostenol (day 5) + 50 μg GnRH (day 7) + insemination at fixed time (AIFT) 12 to 14 h after last injection of GnRH; T3 (n=15), 100 μg GnRH (day 0) + 7.5 mg D-Chloprostenol (day 5) + 100 μg GnRH (day 7) + AIFT 12 to 14 h after last injection of GnRH. Results. The average concentration of progesterone (P4) in blood was 1.22 ± 0.74 ng/mL, which was used to verify ovarian activity at the beginning of the treatments. 100% of the T1 ewes presented estrus, beginning at 38.4±9.56 h after sponge removal. There were differences (p<0.05) for pregnancy rates, of 60, 33.33 and 46.66% respectively, among the treatments. Prolificacy was no different (p>0.05) among the treatments where the values were 1.2, 1.4 and 1.4 lambs/ewe for T1, T2 and T3, Conclusions. The results of this study show that the use of GnRH and D-Chloprostenol did improve pregnancy rates but did not improve prolificacy in tropical ewes

Author(s):  
Abubakr O. Ismail ◽  
◽  
Erneo B. Ochi ◽  
Ambrose S. Jubara ◽  
Bakri Ahmed A/Rahim ◽  
...  

A comparative hormonal study of prostaglandin, gonadotropin releasing hormone and their combination was conducted on 30 randomly selected cross-bred dairy cows of SEMEX project for artificial insemination in Hillat Kuku, Khartoum North, Sudan. The study attempts to determine the response of the animals to hormonal induction and synchronization of estrous as well as fertility following fixed time artificial insemination. Three treatment groups of 10 cows each were undertaken. Groups 1, 2 and 3 involved administration of prostaglandin F2α (PGF2α), gonadotropin releasing hormone (GnRH) and a combination of PGF2α + GnRH, respectively. Descriptive statistical analysis was performed. The results revealed that all the three protocols induced and synchronized estrous were almost synchronous in all the treated groups. However, protocol 3 revealed a significantly (p<0.05) better result of 70% pregnancy rate compared to other two protocols that equally provided 50% pregnancy rates. The study resolves that protocol 3 be highly recommended to change the mindset of farmers about the spread of reproductive technology in Sudan. Protocols 1 and 2 provided acceptable pregnancy rates that can be enhanced with the improvement of management.


2015 ◽  
Vol 27 (1) ◽  
pp. 96 ◽  
Author(s):  
A. Menchaca ◽  
R. Nuñez-Olivera ◽  
F. Cuadro ◽  
G. Bo

An oestradiol-based protocol (named J-Synch) has been developed recently with the aim of providing for a longer proestrus, enhancing the development of the dominant follicle before ovulation, and increasing pregnancy rates following fixed-time AI (FTAI) in heifers (de la Matta and Bo 2012 Taurus 55, 17–23). Two experiments were performed in Uruguay with 1953 Angus × Hereford crossbred heifers to compare pregnancy rates obtained with the J-Synch protocol with the conventional 7-day oestradiol-based protocol. A secondary objective was to determine the effects of the time of FTAI and the addition of eCG at the time progestin device removal on pregnancy rates. In Experiment 1, 966 heifers received a DIB device (0.5 g of progesterone, Syntex, Buenos Aires, Argentina) plus 2 mg of oestradiol benzoate IM (Syntex) on Day 0. Heifers in the conventional treatment group (n = 485) received cloprostenol (500 μg, Ciclase DL, Syntex) and oestradiol cypionate (0.5 mg, Cipiosyn, Syntex) IM and had their DIB removed on Day 7 a.m. Heifers in this group were then subdivided to be FTAI on Day 9 a.m. or p.m. (i.e. 48 or 56 h after DIB removal). Heifers in the J-Synch treatment group (n = 481) received cloprostenol IM and DIB removal on Day 6 p.m. and received gonadotropin-releasing hormone (100 μg gonadorelin acetate, Gonasyn Gdr, Syntex) on Day 9 a.m.; heifers were then FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). All heifers in this experiment were also treated with 300 IU of eCG (Novormon, Syntex) at DIB removal. In Experiment 2, 987 heifers were treated with the J-Synch protocol as described in Experiment 1. At device removal (Day 6 p.m.), heifers were divided to receive (n = 488) or not (n = 499) 300 IU of eCG IM at that time and were further subdivided to receive gonadotropin-releasing hormone and FTAI on Day 9 a.m. or p.m. (i.e. 60 or 72 h after DIB removal). Pregnancy rates were determined by ultrasonography 30 days after FTAI. Data were analysed using logistic regression, and results are shown in Table 1. J-Synch-treated heifers tended (P < 0.1) to have higher pregnancy rates following FTAI, whereas time of FTAI only affected pregnancy rates following the conventional 7-day treatment (P < 0.05). However, removal of eCG from the J-Synch protocol in Experiment 2 resulted in reduced pregnancy rates when inseminations were done on Day 9 p.m. (P < 0.05). In summary, the addition of eCG to the J-Synch protocol provided for a wider window of insemination times facilitating FTAI in large groups of beef heifers. Table 1.Effect of length of progestin insertion, time of insemination and eCG treatment on pregnancy rates in beef heifers


2010 ◽  
Vol 90 (1) ◽  
pp. 23-34 ◽  
Author(s):  
J A Small ◽  
M G Colazo ◽  
J P Kastelic ◽  
N E Erickson ◽  
R J Mapletoft

Three experiments were conducted to determine the effects of presynchronization and treatment with equine chorionic gonadotropin (eCG) on corpus luteum (CL) and ovarian follicular development, plasma progesterone concentrations, and pregnancy rates in beef heifers subjected to a gonadotropin releasing hormone (GnRH)-based, fixed-timed AI (TAI) protocol. All heifers were given GnRH on day 0, prostaglandin F2α (PGF) on day 7, and a second GnRH on day 9 concurrent with TAI (54 h after PGF). In exp. 1 (N = 148), presynchronization with PGF (days -22 and -11) decreased the percentage of heifers with non-luteal plasma progesterone concentrations on day 0 (5.4 vs 29.7%) and day 7 (0 vs 11.6%; P < 0.05), but not on day 9 (74.3 vs. 66.2%; P > 0.20), and reduced the number of heifers in estrus and bred before TAI (P < 0.05). Although presynchronization reduced preovulatory follicle diameter (12.9 ± 0.3 vs. 14.9 ± 0.3 mm; mean ± SEM; P < 0.01), it did not affect TAI pregnancy rates (36.5 vs. 29.7%; P > 0.20). In exp. 2, heifers (N = 128) were presynchronized with melengestrol acetate (MGA) (days -27 to -12), and received a controlled internal drug release (CIDR) on day 0; on day 7, half were given 300 IU of eCG at CIDR removal. Treatment with eCG tended to increase preovulatory follicle diameter in heifers that did not ovulate to GnRH on day 0 (P = 0.06), but did not affect the percentage of heifers with non-luteal plasma progesterone concentrations on day 9 (57.8 vs. 57.8%) or TAI pregnancy rates (48.4 vs. 53.1%; P > 0.20). Experiment 3 was a 2 × 2 factorial arrangement of presynchronization (PGF concurrent with a CIDR on day -7) and eCG treatments (on day 7) applied to heifers in three herds (A, N = 150, B, N = 260 and C, N = 40). All heifers had a once-used CIDR from days 0 to 7. Presynchronization increased the percentage of heifers (Herd A) with low-luteal plasma progesterone concentrations on day 0 (70.7 vs. 22.7%) and day 7 (90.7 vs. 53.3%; P < 0.01), but did not affect the percentage of heifers with non-luteal concentrations of progesterone on day 9 (97.3 vs. 93.3%; P > 0.20). Combined for all herds, presynchronization reduced the prevalence of a CL on day 0 (23.5 vs. 73.7%; P < 0.01), and increased the prevalence of follicles ≥ 10 mm on day 7 (96.8 vs. 86.7%; P < 0.01); however, TAI pregnancy rates (195/439 = 44.4%) were not improved by either presynchronization or eCG treatment (P > 0.20).Key words: Presynchronization, equine chorionic gonadotropin, GnRH, fixed-time artificial insemination, progesterone


2017 ◽  
Vol 29 (1) ◽  
pp. 160
Author(s):  
A. Tribulo ◽  
A. Cedeño ◽  
B. Bernal ◽  
S. Andrada ◽  
J. L. Barajas ◽  
...  

A retrospective analysis evaluated pregnancy rates and embryo losses with in vitro-produced embryos in a commercial embryo transfer program on 15 different beef farms. Recipients were beef cows and heifers (n = 1841) that were synchronized with 5 different protocols and transferred at a fixed-time (FTET). Recipients were examined by ultrasonography on Day 0, and those with a corpus luteum (CL) or a follicle ≥8 mm in diameter and with body condition score 2 to 4 (1 to 5 scale) were synchronized. The synchronization treatments were as follows. (T1) Recipients received an intravaginal device with 0.5 g of progesterone plus 2 mg of oestradiol benzoate on Day 0; device removal, plus 500 μg of cloprostenol (prostaglandin F2α), 400 IU of eCG, and 0.5 mg of oestradiol cypionate on Day 8; and FTET on Day 17. (T2) This treatment was similar to T1 but 1 mg of oestradiol cypionate was injected at device removal instead of 0.5 mg of oestradiol cypionate. (T3) This treatment was similar to T1 except that animals were tail-painted on Day 8 and observed on Day 10. Those with the tail-paint intact on Day 10 received 100 μg of gonadorelin (gonadotropin-releasing hormone) and all recipients were FTET on Day 17. (T4) Recipients received a progesterone device on Day 0; device removal, prostaglandin F2α, and eCG on Day 5; gonadotropin-releasing hormone on Day 8; and FTET on Day 15. (T5) Recipients received a progesterone device and 2 mg of oestradiol benzoate on Day 0; device removal, prostaglandin F2α, and eCG on Day 6; gonadotropin-releasing hormone on Day 9; and FTET on Day 16. On the day of FTET all recipients with CL ≥18 mm in diameter (G1), ≥16 and <18 mm in diameter (G2), and ≥14 mm and <16 mm in diameter (G3) received in vitro-produced fresh embryos. Pregnancy was diagnosed by ultrasonography at 30 and 60 days of gestation, and data were analysed by logistic regression. The overall proportion of recipients synchronized that were FTET was 80.8% (1487/1841), with a 30-day pregnancy rate to FTET (P/FTET) of 45.6% (678/1487) and the rate of 30- to 60-day embryo/fetal loses on the 528 recipients that were re-checked at 60 days was 12.8% (68/528). There were no significant differences in P/FTET among operators, animal category, time of the year, embryo stage, or body condition score; however, there was a significant effect of farm (P < 0.001) and CL diameter (P < 0.05), but no interaction between CL diameter and farm or treatment (P > 0.1). Recipients with G1 (443/953, 46%) and G2 (221/462, 47%) CL had higher pregnancy rates than those with G3 CL (23/71, 32%). There was a significant effect of synchronization treatment on the proportion of recipients transferred and on P/FTET (P < 0.01) that was highly influenced by farm (farm by treatment interaction P < 0.01). The proportions of recipients selected for embryo transfer were as follows: T1: 386/486, 79.4%; T2: 233/331, 70.3%; T3: 342/377, 90.7%; T4: 126/160, 78.7%; and T5: 400/487, 82.1%. The P/FTET were as follows: T1: 190/386, 49.2%; T2: 96/233, 41.2%; T3: 175/342, 51.1%; T4: 49/126, 38.8%; and T5: 168/400, 42.0%. Although 30- to 60-day embryo/fetal losses were not influenced by synchronization treatments, they were highly influenced by farm (P < 0.001) and ranged from 0 to 34.5%. In conclusion, P/FTET in a commercial program with beef in vitro-produced embryos was influenced by factors related to the recipient (CL diameter) and the environment (farm), whereas embryo/fetal losses were influenced by farm but not treatment or recipient factors.


2018 ◽  
Vol 58 (10) ◽  
pp. 1802 ◽  
Author(s):  
C. García-Pintos ◽  
A. Menchaca

It was recently demonstrated that equine chorionic gonadotropin (eCG) treatment 10 days after ovulation increases serum progesterone concentrations in sheep. The objective of the present study was to evaluate pregnancy outcomes induced with the administration of eCG and gonadotropin-releasing hormone (GnRH) after insemination. Three experiments were conducted in multiparous ewes that received fixed-time intrauterine insemination (Day 0) after a progesterone-based protocol for oestrus synchronisation. Experiment 1 consisted of 408 ewes, randomly assigned to three experimental groups; ewes in the first and second group received 400 IU of eCG on Day 5 and Day 10 after insemination respectively, while ewes on the third (control) group did not receive eCG. In Experiment 2, 587 ewes were randomly assigned to four experimental groups (2 × 2 factorial experiment), to receive or not 400 IU of eCG on Day 5, associated or not with 100 µg of GnRH analogue on Day 6 (i.e. 30 h after eCG administration). In Experiment 3, 715 ewes were randomly assigned to four experimental groups (2 × 2 factorial experiment), to receive or not 400 IU of eCG on Day 10, associated or not with 100 µg of GnRH analogue on Day 11 (i.e. 30 h after eCG administration). Pregnancy diagnosis was determined on Day 30 and Day 70 by ultrasonography. The eCG treatment after insemination failed to improve pregnancy outcomes in Experiments 1 and 2. However, in Experiment 3 the treatment with eCG on Day 10 enhanced pregnancy rate on Day 30, although this improvement was not maintained on Day 70, which showed greater pregnancy failure. The administration of GnRH on Day 6 or Day 11, preceded or not by eCG, did not affect any of the variables related to pregnancy. In summary, the improvement in progesterone profiles induced by eCG treatment on Day 10 after insemination, previously reported in sheep, seems to have a marginal positive effect on pregnancy establishment during the first month, which is not maintained during the second month of gestation.


2014 ◽  
Vol 57 (3) ◽  
pp. 361-366 ◽  
Author(s):  
Danilo Demeterco ◽  
Darren Dwayne Henry ◽  
Vitor Rodrigues Gomes Mercadante ◽  
Graham Cliff Lamb ◽  
Francisco Romano Gaievski ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document